ALAlphabet Inc.
Institutional investor · Portfolio as of Q1 2026
Top Holdings26 positions
CME Group Inc. | 3.5M | $1B | 25.6% | $292.45 | 0.00% | 1 qtr | New 99 |
PLANET LABS PBC | 35.2M | $985.2M | 24.5% | $8.19 | +241.07% | 18 qtrssince 2021-Q4 | Increased 69 |
AST SPACEMOBILE INC | 8.9M | $741.1M | 18.5% | $22.74 | +264.42% | 5 qtrssince 2025-Q1 | Unchanged 0 |
REVOLUTION MEDICINES INC | 3.3M | $320.2M | 8.0% | $28.69 | +238.96% | 10 qtrssince 2023-Q4 | Decreased 0 |
ARM HOLDINGS PLC | 2M | $296.6M | 7.4% | $53.52 | +182.66% | 11 qtrssince 2023-Q3 | Unchanged 0 |
FRESHWORKS INCCL A | 16.2M | $130.1M | 3.2% | $18.61 | -56.85% | 18 qtrssince 2021-Q4 | Unchanged 0 |
UIPATH INC CLASS A | 7M | $78.1M | 1.9% | $67.93 | -83.66% | 20 qtrssince 2021-Q2 | Unchanged 0 |
TEMPUS AI INCCL A | 1.6M | $70.1M | 1.7% | $35.00 | +29.20% | 8 qtrssince 2024-Q2 | Unchanged 0 |
PAYPAY CORP | 3.1M | $66.7M | 1.7% | $21.34 | 0.00% | 1 qtr | New 69 |
GITLAB INCCL A | 2.7M | $59M | 1.5% | $54.98 | -60.64% | 16 qtrssince 2022-Q2 | Unchanged 0 |
PRIME MEDICINE INC | 16.6M | $57.6M | 1.4% | $15.16 | -77.05% | 14 qtrssince 2022-Q4 | Unchanged 0 |
ETHOS TECHNOLOGIES INC | 3.8M | $42.1M | 1.0% | $11.17 | 0.00% | 1 qtr | New 68 |
MAZE THERAPEUTICS INC | 1.4M | $41.4M | 1.0% | $11.01 | +171.12% | 5 qtrssince 2025-Q1 | Unchanged 0 |
BRIDGEBIO ONCOLOGY THERAPEUT | 2.8M | $25.3M | 0.6% | $11.58 | -22.71% | 3 qtrssince 2025-Q3 | Unchanged 0 |
RELAY THERAPEUTICS INC | 1.6M | $15.6M | 0.4% | $41.71 | -76.14% | 23 qtrssince 2020-Q3 | Decreased 0 |
MONTE ROSA THERAPEUTICS INC | 684,275 | $11.3M | 0.3% | $22.70 | -27.53% | 20 qtrssince 2021-Q2 | Decreased 0 |
VERA THERAPEUTICS INC | 241,264 | $9.7M | 0.2% | — | — | 20 qtrssince 2021-Q2 | Unchanged 0 |
SANA BIOTECHNOLOGY INC | 2.8M | $8.1M | 0.2% | $33.47 | -91.40% | 21 qtrssince 2021-Q1 | Unchanged 0 |
BEAM THERAPEUTICS INC | 321,604 | $7.7M | 0.2% | $18.00 | +32.39% | 25 qtrssince 2020-Q1 | Unchanged 0 |
LYELL IMMUNOPHARMA INC | 293,256 | $5.9M | 0.1% | $8.84 | +126.92% | 4 qtrssince 2025-Q2 | Unchanged 0 |
Alphabet Inc. manages $4B across 26 positions as of Q1 2026. Top holdings: CME (25.6%), PL (24.5%), ASTS (18.5%). Fund DNA: Concentrated Value. HoldingsIntel Score: 2.5/5.0.
Added CME, PAYP and LIFE; exited DXCM, WGS, EXAS and 3 more; increased 1, led by PL (+3.3M shares); trimmed 3, led by RVMD (−52,577 shares). Top move: CME (NEW, conviction 99). Portfolio: $4.0B across 26 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
No active accumulation streaks detected for this filer.
Streaks require 2+ consecutive quarters of increased positions in the most recent period.
Continue exploring
Famous Investors' Portfolios
What the most-followed managers hold, and what they bought and sold each quarter.
- Warren Buffett (Chairman Emeritus)Berkshire Hathaway
- Leopold AschenbrennerSituational Awareness
- Michael BurryScion Asset Management
- Cathie WoodARK Invest
- Bill AckmanPershing Square
- Stanley DruckenmillerDuquesne Family Office
- David TepperAppaloosa
- Ray Dalio (Founder)Bridgewater Associates
- Li LuHimalaya Capital
- Carl IcahnCarl C. Icahn
- Brad GerstnerAltimeter Capital
- Seth KlarmanThe Baupost Group
- Howard Marks (Co‑founder)Oaktree Capital Management
- Ken GriffinCitadel
- Paul Tudor JonesTudor Investment Corp
- George Soros (Founder)Soros Fund Management
- Steve CohenPoint72
- Terry SmithFundsmith
- Ken Fisher (Founder)Fisher Investments
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR